Truist Securities Maintains Hold on Inspire Medical Systems, Lowers Price Target to $50

Benzinga Newsdesk www.benzinga.com Negative 53.3%

Neg 53.3% Neu 0% Pos 0%

Truist Securities analyst Richard Newitter maintains Inspire Medical Systems (NYSE:INSP) with a Hold and lowers the price target from $64 to $50.